Construction of a novel quinoxaline as a new class of Nrf2 activator
Abstract Background The transcription factor Nuclear factor erythroid-2-related factor 2 (NRF2) and its principal repressive regulator, Kelch-like ECH-associated protein 1 (KEAP1), are perilous in the regulation of inflammation, as well as maintenance of homeostasis. Thus, NRF2 activation is involve...
Main Authors: | Murugesh Kandasamy, Kit-Kay Mak, Thangaraj Devadoss, Punniyakoti Veeraveedu Thanikachalam, Raghavendra Sakirolla, Hira Choudhury, Mallikarjuna Rao Pichika |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | BMC Chemistry |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13065-019-0633-4 |
Similar Items
-
Anti-Inflammatory Effects of Auranamide and Patriscabratine—Mechanisms and In Silico Studies
by: Kit-Kay Mak, et al.
Published: (2022-08-01) -
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
by: Farhad Pouremamali, et al.
Published: (2022-06-01) -
The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
by: Keiko Taguchi, et al.
Published: (2020-12-01) -
Modulation of NRF2/KEAP1 Signaling in Preeclampsia
by: Giovanni Tossetta, et al.
Published: (2023-06-01) -
Nrf2 in cancers: A double‐edged sword
by: Shijia Wu, et al.
Published: (2019-05-01)